Search results
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 5 hours agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
AstraZeneca pulls its COVID-19 vaccine from the European market
WSB-TV 2 Atlanta· 7 days agoLONDON — (AP) — The pharma giant AstraZeneca has requested that the European authorization for its...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 23 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Is This a Setback for Moderna?
Motley Fool via Yahoo Finance· 1 day agoSo, this isn't a setback for Moderna, and investors can breathe a sigh of relief. But it's still important to keep a close eye on the situation for one...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 5 days agoThe FDA has informed Moderna that it is working to conclude...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 5 days agoThe Food and Drug Administration's move prolongs the wait for Moderna's second approved product, but...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 5 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 2 days agoThe review is now expected to be completed by the end of this month. The FDA has, however, not...
